These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23184940)

  • 1. Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo.
    Chambers JW; Howard S; LoGrasso PV
    J Biol Chem; 2013 Jan; 288(2):1079-87. PubMed ID: 23184940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of mitochondrial JNK signaling achieved using peptide mimicry of the Sab kinase interacting motif-1 (KIM1).
    Chambers JW; Cherry L; Laughlin JD; Figuera-Losada M; Lograsso PV
    ACS Chem Biol; 2011 Aug; 6(8):808-18. PubMed ID: 21563797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JNK activation and translocation to mitochondria mediates mitochondrial dysfunction and cell death induced by VDAC opening and sorafenib in hepatocarcinoma cells.
    Heslop KA; Rovini A; Hunt EG; Fang D; Morris ME; Christie CF; Gooz MB; DeHart DN; Dang Y; Lemasters JJ; Maldonado EN
    Biochem Pharmacol; 2020 Jan; 171():113728. PubMed ID: 31759978
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chu Q; Zhang Y; Zhong S; Gao F; Chen Y; Wang B; Zhang Z; Cai W; Li W; Zheng F; Shi G
    Oxid Med Cell Longev; 2019; 2019():7417561. PubMed ID: 31205589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: Mitochondrial protection and antioxidant properties.
    Fonseca-Fonseca LA; da Silva VDA; Wong-Guerra M; Ramírez-Sánchez J; Yaquis ASP; Ochoa-Rodríguez E; Verdecia-Reyes Y; de Araújo FM; Santana RC; Outeiro TF; Costa SL; Núñez-Figueredo Y
    Neurotoxicology; 2021 Jan; 82():89-98. PubMed ID: 33232743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity.
    Chang JC; Wu SL; Liu KH; Chen YH; Chuang CS; Cheng FC; Su HL; Wei YH; Kuo SJ; Liu CS
    Transl Res; 2016 Apr; 170():40-56.e3. PubMed ID: 26730494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
    Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
    Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sab (Sh3bp5) dependence of JNK mediated inhibition of mitochondrial respiration in palmitic acid induced hepatocyte lipotoxicity.
    Win S; Than TA; Le BH; García-Ruiz C; Fernandez-Checa JC; Kaplowitz N
    J Hepatol; 2015 Jun; 62(6):1367-74. PubMed ID: 25666017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways.
    Pan J; Wang G; Yang HQ; Hong Z; Xiao Q; Ren RJ; Zhou HY; Bai L; Chen SD
    Mol Pharmacol; 2007 Dec; 72(6):1607-18. PubMed ID: 17855652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of FasL and its interaction with Fas are mediated by c-Jun N-terminal kinase (JNK) pathway in 6-OHDA-induced rat model of Parkinson disease.
    Pan J; Zhao YX; Wang ZQ; Jin L; Sun ZK; Chen SD
    Neurosci Lett; 2007 Nov; 428(2-3):82-7. PubMed ID: 17959308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson's Disease.
    Voshavar C; Shah M; Xu L; Dutta AK
    Neurotox Res; 2015 Nov; 28(4):302-18. PubMed ID: 26201265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine.
    Eminel S; Klettner A; Roemer L; Herdegen T; Waetzig V
    J Biol Chem; 2004 Dec; 279(53):55385-92. PubMed ID: 15504737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells.
    Kwon SH; Ma SX; Hong SI; Kim SY; Lee SY; Jang CG
    J Ethnopharmacol; 2014 Feb; 152(1):173-82. PubMed ID: 24440915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human albumin prevents 6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.
    Zhang LJ; Xue YQ; Yang C; Yang WH; Chen L; Zhang QJ; Qu TY; Huang S; Zhao LR; Wang XM; Duan WM
    PLoS One; 2012; 7(7):e41226. PubMed ID: 22815976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurokinin receptor 3 peptide exacerbates 6-hydroxydopamine-induced dopaminergic degeneration in rats through JNK pathway.
    Chu JM; Chan YS; Chen LW; Yung KK
    J Neurochem; 2012 Nov; 123(3):417-27. PubMed ID: 22762252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Hydroxydopamine impairs mitochondrial function in the rat model of Parkinson's disease: respirometric, histological, and behavioral analyses.
    Kupsch A; Schmidt W; Gizatullina Z; Debska-Vielhaber G; Voges J; Striggow F; Panther P; Schwegler H; Heinze HJ; Vielhaber S; Gellerich FN
    J Neural Transm (Vienna); 2014 Oct; 121(10):1245-57. PubMed ID: 24627045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Jun N-terminal kinase mediates mouse liver injury through a novel Sab (SH3BP5)-dependent pathway leading to inactivation of intramitochondrial Src.
    Win S; Than TA; Min RW; Aghajan M; Kaplowitz N
    Hepatology; 2016 Jun; 63(6):1987-2003. PubMed ID: 26845758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun N-terminal kinase (JNK)-dependent acute liver injury from acetaminophen or tumor necrosis factor (TNF) requires mitochondrial Sab protein expression in mice.
    Win S; Than TA; Han D; Petrovic LM; Kaplowitz N
    J Biol Chem; 2011 Oct; 286(40):35071-8. PubMed ID: 21844199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.
    Antunes MS; Ladd FVL; Ladd AABL; Moreira AL; Boeira SP; Cattelan Souza L
    Metab Brain Dis; 2021 Jan; 36(1):153-167. PubMed ID: 33057922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.